Cancellation of the remaining publicly held registered shares of Acino Holding AG
Monday 7th July 2014
With decision dated June 26, 2014, the Cantonal court of Basel-Landschaft has admitted the claim of Pharma Strategy Partners GmbH, Aesch, for the cancellation of the remaining publicly held shares of Acino Holding AG with a par value of CHF 0.40 each. The decision has not yet become final and enforceable and may be appealed by the parties with the Federal Supreme Court.
The delisting – which has been approved by SIX Swiss Exchange (SIX) on December 20, 2013 – will take place as soon as the decision of the Cantonal court of Basel-Landschaft becomes final and enforceable.
